Alchip — AGM Information 2026

Apr 22, 2026

英屬開曼群島商世芯電子股份有限公司
Alchip Technologies, Ltd.
民國115年股東常會議案參考資料
Reference of 2026 Annual General Meeting

時間：民國一一五年五月二十六日（星期二）上午九時正
Time: 09:00 a.m. on Tuesday, May 26, 2026

地點：台北市中山區敬業四路168號3樓（維多麗亞酒店）
Venue: 3F, No. 168, Jingye 4th Rd., Zhongshan Dist., Taipei City (Grand Victoria Hotel)

股東會召開方式：實體股東會
The means of Shareholders meeting: Physical Shareholders meeting

出席：全體股東及股權代表人
Attendants: All shareholders or their proxy holders

主席：沈董事長 翔霖
Chairman: Mr. Shen Johnny Shyang-Lin, Chairman of the Board of Directors

一、主席宣布開會
Call the Meeting to Order

二、主席致詞
Chairman’s Address

三、報告事項：
（一）民國114年度營業狀況報告。
（二）審計委員會審查民國114年度決算表冊報告。
（三）員工及董事酬勞分配情形報告。
（四）民國114年度私募普通股辦理情形報告。

1. Report Items
   (1) The Business Report of 2025.
   (2) Audit Committee’s Review Report on 2025 Consolidated Financial Statements.
   (3) The Distribution of Bonus to Employees and Directors of the Company.
   (4) 2025 Private Placement of Common Shares Processing Status Report.

四、承認事項：
（一）民國114年度營業報告書及財務報表案。
（二）民國114年度盈餘分配案。

---

1. Proposed Resolutions

(1) 2025 Business Report and the Consolidated Financial Statements for the year ended December 31, 2025 of the Company.
(2) 2025 Profit Distribution Proposal.

五、討論事項：

（一）修訂取得或處分資產處理程序案。
（二）以現金增資發行普通股參與發行海外存託憑證案。
（三）本公司辦理私募普通股案（應以特別決議通過）。
（四）解除董事競業禁止案（應以特別（重度）決議通過）。

1. Discussion Items

(1) Amendments to the Procedures for the Acquisition and Disposal of Assets.
(2) The Issuance of New Common Shares by Cash Capital Increase for Sponsoring GDR Issuance.
(3) The Company's Issuance of Common Shares through Private Placement (By way of a Special Resolution).
(4) Release the Prohibition on Directors from Participating in Competitive Business (By way of a Supermajority Resolution).

六、臨時動議

1. Ad Hoc Motion

七、散會

1. Adjournment

---

一、報告事項 Report Items

報告案一

案由：民國114年度營業狀況報告，報請 公鑑。

說明：本公司民國114年度營業報告書，請參閱本公司議事手冊附件一。

Report No.1：

The Business Report of 2025.

Explanation:

Please refer to Exhibit I in the handbook for 2026 Annual General Meeting of the Company for 2025 Business Report.

報告案二

案由：審計委員會審查民國114年度決算表冊報告，報請 公鑑。

說明：審計委員會審查報告書，請參閱本公司議事手冊附件二。

Report No.2：

Audit Committee’s Review Report on 2025 Consolidated Financial Statements.

Explanation:

Please refer to Exhibit II in the handbook for 2026 Annual General Meeting of the Company for Audit Committee’s Review Report.

報告案三

案由：員工及董事酬勞分配情形報告，報請 公鑑。

說明：一、依公司章程第34.1條規定，本公司年度如有獲利，應提撥當年度獲利不低於1%為員工酬勞及不高於2%為董事酬勞。當年度獲利狀況係指當年度稅前利益扣除分派員工酬勞及董事酬勞前之利益。

二、本公司擬以現金方式分派員工酬勞美金9,000,000元及董事酬勞美金1,400,000元。

Report No.3：

Distribution of Bonus to Employees and Directors of the Company.

Explanation:

1. In accordance with Article 34.1 of the Memorandum and Articles of Association of the Company, the Company shall set aside no less than 1% of its annual profits as bonus to employees of the Company and set side no more than 2% of its annual profits as bonus to Directors. The annual profits specified in the Article refers to the annual income before tax and before bonuses are set aside for employees and Directors.

2. The Company proposes to distribute US$9,000,000 to employees and US$1,400,000 to Directors in cash.

報告案四

案由：民國114年度私募普通股辦理情形報告案，報請 公鑑。

說明：本公司114年股東年常會通過私募發行普通股1,500,000股，擬於115年5月8日董事會決議是否發行，並於股東常會補充報告。

---

Report No. 4

2025 Private Placement of Common Shares Processing Status Report.

Explanation:

The Company's 2025 Annual Shareholders' Meeting approved a private placement of 1,500,000 common shares. The Board of Directors plans to resolve whether to proceed with the issuance on May 8, 2026, and will provide a supplemental report at the shareholders' meeting.

---

二、承認事項 Proposed Resolutions

承認案一

董事會提

案由：民國114年度營業報告書及財務報表案，提請承認。

說明：一、本公司民國114年度營業報告書請參閱本公司議事手冊附件一。

二、本公司民國114年度合併財務報告，包括：資產負債表、綜合損益表、權益變動表、現金流量表，業經勤業眾信聯合會計師事務所劉建良及張麗君會計師查核簽證完竣，並出具查核報告書在案。

三、民國114年度會計師查核報告及上述合併財務報表，請參閱本公司議事手冊附件三。

決議：

Proposal No.1：

Proposed by the Board of Directors

2025 Business Report and the Consolidated Financial Statements for the year ended December 31, 2025 of the Company.

Explanation:

(1) Please refer to Exhibit I in the handbook for 2026 Annual General Meeting of the Company for 2025 Business Report.

(2) The Company's 2025 Consolidated Financial Statements, including Balance Sheet, Statements of Comprehensive Income, Statements of Changes in Equity and Statements of Cash flows, were audited by independent auditors, Mr. Chien-Liang Liu and Ms. Li-Chun Chang of Deloitte & Touche.

(3) Please refer to Exhibit III in the handbook for 2026 Annual General Meeting of the Company for the independent auditors' audit report and the above-mentioned Consolidated Financial.

Resolutions：

承認案二

董事會提

案由：民國114年度盈餘分配案，提請承認。

說明：一、民國114年度盈餘分配，業經民國115年3月6日董事會依公司章程規定擬具分派如下表。

二、本案俟股東常會通過後，授權董事會訂定除息基準日及其他相關事宜。

三、本次盈餘分派於除息基準日前，若基於法令變更、主管機關要求、本公司買回公司股份/員工認股權之行使等因素，影響流通在外股份數量，致使股東配息比率發生變動而需修正時，授權董事會全權處理。

Alchip Technologies, Limited
114年度盈餘分配表

單位：美金元

114年度期初未分配盈餘		248,406,916
因採用權益法之投資調整保留盈餘		(174,553)
本期稅後淨利		179,549,075
本期可供分配盈餘		427,781,438
分配項目
現金股利(每股配發美金1.08574元)		(88,275,709)
114年度期末未分配盈餘		339,505,729

---

註:1. 每股股利係以 115 年 1 月 31 日止流通在外股數 81,304,648 股計算，實際每股股利將以除息基準日本公司實際流通在外股份為準，惟分派總額不變。
2. 本公司於 115 年 3 月 6 日董事會決議發放每股現金股利 1.08574 美元(換算成新台幣 34.41 元)，美金換算成新台幣匯率係依 115 年 3 月 5 日台灣銀行之即期買入及賣出之均價估算，實際金額應以股務代理機構收到現金股利後，依當時匯率兌換成新台幣之金額為準，股利發放至元為止，其畸零款合計數計入本公司之其他收入。

決議：

Proposal No.2：
Proposed by the Board of Directors
2025 Profit Distribution Proposal.

Explanation:
(1) The Board has adopted a proposal for 2025 Profit Distribution on March 6, 2026 in accordance with the Memorandum and Articles of Association of the Company. Please refer to 2025 Profit Distribution table below.
(2) Upon the approval of the Annual Meeting of Shareholders, it is proposed that the Board of Directors be authorized to resolve the dividend record date, and other relevant issues.
(3) In the event that, before the dividend record date, the proposed profit distribution is affected by an amendment to relevant laws or regulations, a request by the competent authorities, or a buyback of shares or employee stock options exercise, it is proposed that the Board of Directors be authorized to adjust the cash to be distributed to each share based on the number of actual shares outstanding on the record date for distribution.

| Alchip Technologies, Limited
Profit Distribution Table
Year 2025 | |
| --- | --- |
| (Unit: USD) | |
| 2025 Beginning retained earnings | 248,406,916 |
| Adjustment of retained earnings due to investments
accounted for using equity method | (174,553) |
| Net profit after tax | 179,549,075 |
| Distributable net profit | 427,781,438 |
| Distribution item | |
| Dividend to shareholder (US$1.08574 per share) | (88,275,709) |
| 2025 Unappropriated retained earning | 339,505,729 |

Note: 1. The calculation of the dividend per share is based on the total number of outstanding shares which were 81,304,648 shares as of January 31, 2026. The price of the actual dividend per share will be calculated on the Record date for the distribution. The total amount of dividends is fixed.
2. On March 6, 2026, the Board resolved to issue shareholders a dividend of US$1.08574 (converted into NT$34.41) per share. This foreign exchange rate is based on the spot rate set by Bank of Taiwan on March 5, 2026. The actual dividend should be subject to the exchange rate of conversion upon receipt of the dividend by the Company's stock agent. The cash dividend will round down to the nearest NT Dollar. The amounts under one NT dollar due to the rounding off are summed up and recognized as the Company's other income.

Resolutions:

---

三、討論事項 Discussion Items

討論案一

董事會 提

案由：修訂取得或處分資產處理程序案，提請討論。

說明：本公司為因應公司實務需求，擬修訂取得或處分資產處理程序部分條文，提請股東會決議。修正條文對照表請參閱本公司議事手冊附件四。

決議：

Discussion No.1：

Proposed by the Board of Directors

Amendment to the “Procedures for the Acquisition and Disposal of Assets”. Please proceed to discuss.

Explanation:

It is proposed that the “Procedures for the Acquisition and Disposal of Assets” be amended and approved at the Annual General Meeting in order to comply with the relevant laws and regulations and the needs of commercial practice. Please refer to Exhibit IV in the handbook of 2026 Annual General Meeting of the Company for details.

Resolutions:

討論案二

董事會 提

案由：本公司辦理以現金增資發行普通股參與發行海外存託憑證案，提請討論。

說明：

一、為支應本公司未來營運資金需求，並使資金募集管道多元化，本公司規劃以現金增資發行普通股參與發行海外存託憑證籌集資金，提請股東會授權董事會於適當時機，視當時金融市場狀況，自股東會決議之日起一年內於不超過6,000,000股普通股之範圍內調整發行額度，以籌措資金。

二、除依章程第8.3條規定，保留發行普通股總數之 10% 由公司員工認購外，其餘 90% 依證券交易法第28條之1及公司章程第8.2條規定，提請股東會同意由原股東放棄優先認購之權利，全部提撥對外公開發行，以充作參與發行本次海外存託憑證之原有價證券。本次員工未認購部分，授權由董事長洽特定人認購或得視市場需要列入參與發行海外存託憑證之有價證券。

三、本次以現金增資發行普通股參與發行海外存託憑證之發行價格，將依中華民國證券商業同業公會「承銷商會員輔導發行公司募集與發行有價證券自律規則」規定，不得低於訂價日本公司收盤價、訂價日前一、三、五個營業日擇一計算之普通股收盤價之簡單算術平均數扣除無償配股除權（或減資除權）及除息後平均股價之九成。惟若國內相關法令發生變動時，亦得配合法令規定調整訂價方式。本次現金增資之訂價方式均係依據主管機關相關法令辦理，訂價之依據係屬合理，惟鑑於國內股價常有劇烈短期波動，實際發行價格將於前述範圍內，

7

---

授權由董事長依國際慣例，並參考國際資本市場、國內市場情形等，與證券承銷商共同議定之，以提高海外投資人之接受度。如以本次辦理現金增資發行新股參與發行海外存託憑證之額度上限6,000,000股計算，加計2026年2月28日止股本(81,334,148股)的基礎上計算，對原股東股權稀釋比率約 6.87%，惟為追求公司競爭力提升，並使國際知名度及企業形象推展，在公司長期發展情形下，對股東權益應具正面效益。此外，本次海外存託憑證發行價格的決定方式，係以本公司普通股在國內集中交易市場所形成之公平交易市價為依據，原股東仍得以接近海外存託憑證之發行價格，於國內股市購入本公司普通股股票，且尚無須負擔匯兌風險及流動性風險，故應不致對原股東權益造成重大不利影響。

四、本次現金增資發行普通股參與發行海外存託憑證，所募集之資金預計用於購置原物料及機器設備、充實營運資金、轉投資等多項用途，並預計於資金募集完成後三年左右執行完畢，本計劃之執行預計可強化公司之競爭力，提升營運效能之效益，對股東權益有其正面助益。

五、為本次現金增資發行普通股參與發行海外存託憑證，本公司擬向相關主管機關（包括中華民國金融監督管理委員會、臺灣證券交易所及中央銀行）申請核准。

六、本次現金增資發行普通股參與發行海外存託憑證發行之新股，其權利義務與已發行之普通股相同。

七、本次現金增資發行普通股參與發行海外存託憑證之重要內容，包括發行價格、發行股數、募集金額、發行辦法、計劃項目、預定進度與預計可能產生效益等事項及其他一切有關事項，提請股東會同意授權董事會視市場狀況調整、訂定與辦理。未來如經主管機關指示或基於營運評估或因應客觀環境或市場狀況變動而欲修正者，亦提請股東會授權董事會全權處理。

八、為配合本次辦理現金增資發行普通股參與發行海外存託憑證之發行作業，包括但不限於國內外承銷商、國內外律師、存託機構、保管機構之遴選，提請股東會授權董事長或其指定之人核可，並代表本公司簽署一切有關現金增資發行普通股參與發行海外存託憑證之相關文件，及為本公司辦理一切有關現金增資發行普通股參與發行海外存託憑證之事宜。

九、上述事項如有未盡事宜，提請股東會授權董事會依法全權處理之。

決議：

Discussion No.2

Proposed by the Board of Directors

The issuance of new common shares by cash capital increase for sponsoring GDR issuance.

Please proceed to discuss.

Explanation:

1. For the purposes of increasing the Company's future working capital or meeting other capital needs of the Company, and diversifying fundraising channels, the Company plans to issue new common shares by cash capital increase for GDR issuance. It is proposed to the shareholders meeting that the Board of Directors be authorized to identify optimal timing and adjust the number of new common shares to be issued, up to 6 million common shares, depending upon

---

the prevailing financial market conditions within one year from the date of resolution by the shareholders meeting in order to raise funds.

1. Pursuant to Article 8.3 of the Memorandum and Articles of Association of the Company, 10% of the new shares which shall be reserved for employee subscription and it is proposed to the shareholders meeting that the shareholders waive their pre-emptive rights to subscribe the remaining 90% of the new shares and such remaining shares shall be allocated for public offering in accordance with Article 28-1 of the Securities and Exchange Act and Article 8.2 of the Memorandum and Articles of Association of the Company and serve as the underlying securities of this issuance of GDR. The Chairman of the Board is authorized to arrange or engage specific persons to subscribe the shares left unsubscribed by the Company's employees at the issue price, or to include the unsubscribed shares as underlying securities through the issuance of GDR depending on market demand.

2. The issue price of the new shares by cash capital increase for the sponsoring GDR issuance shall not be lower than 90% of the closing price of the Company's common shares listed on the Taiwan Stock Exchange on the pricing date, or the simple arithmetic mean of the closing prices of the Company's common shares listed on the Taiwan Stock Exchange for any of the periods of one, three or five days immediately preceding the pricing date, after factoring out ex-rights trading in connection with free distribution of stock dividends (or ex-rights trading in connection with distribution of shares due to capital reduction) and ex-dividend trading in connection with distribution of cash dividends; provided that, the aforesaid pricing formula may be adjusted in accordance with changes to relevant domestic laws and regulations. The pricing method of this cash capital increase is based on relevant laws and regulations and the basis of the pricing is reasonable. In view of the short-term dramatic volatility of domestic share prices from time to time, the Chairman is authorized to determine the issue price within the aforesaid scope in consultation with the underwriter(s), based on international practice, market conditions and aggregate book building status, so as to enhance the attractiveness to overseas investors. If the amount of the new shares to be issued in this cash capital increase for sponsoring GDR issuance is the maximum amount of shares that the Company can issue, i.e., 6 million shares, plus the share capital (81,334,148 shares) as of February 28, 2026, the dilution ratio of shareholding of the shareholders is about 6.87%; however, considering the competitiveness of the Company would be enhanced, the Company's overseas visibility would be increased and the corporate image would be promoted, it shall have positive benefits for the shareholder's rights and interests in the case of the Company's long term development. Additionally, the GDR's issue price is decided based on the fair market price of the Company's common stock. The existing shareholders may purchase common stock in Taiwan's stock market at a price close to the GDR's issue price without having to assume exchange and liquidity risks. This issuance of GDR should not have material impact on existing shareholders' rights and interests.

3. Proceeds from the issuance of common shares by cash capital increase for sponsoring GDR issuance are expected to be used for the following one or multiple purpose(s) within about three

9

---

years after completion of such issuance: procurement of raw materials and equipment, working capital increase and/or re-investment. The execution of this plan is expected to bolster the Company's competitiveness, enhance operating efficiency and have a positive effect on the shareholders' rights and interests.

1. For this issuance of new common shares by cash capital increase for sponsoring GDR issuance, the Company plans to file the applications for approval to relevant regulatory authorities (including the Financial Supervisory Commission, Taiwan Stock Exchange and Central Bank of Republic of China (Taiwan).

2. The rights and obligations of the new common shares to be issued by cash capital increase for sponsoring GDR issuance are identical to those of the outstanding common shares of the Company.

3. It is proposed to the shareholders meeting that the Board of Directors be authorized to adjust, decide and handle, in view of market condition, all material matters in connection with the issuance of new common shares by cash capital increase for sponsoring GDR issuance, including issue price, number of shares to be issued, the amount to be raised, offering plan, items for the funds usage plan, schedule, fund utilization plan, expected benefits, and other relevant matters, including necessary amendments to be made per the instructions of the competent authority, based on operational assessment or in consideration of changes in objective environment, market conditions, or other circumstances surrounded.

4. For the purpose of cash capital increase by issuing new common shares for sponsoring GDR issuance, it is proposed to the shareholders meeting to authorize the Chairman or the person designated by the Chairman with full power and authority to approve, sign and execute on behalf of the Company any and all documents regarding the cash capital increase by issuing new common shares for sponsoring GDR issuance and conduct all matters in connection with such offering for the Company, including but not limited to selection of international and domestic underwriters, attorneys, depository institutions and custodian institutions.

5. For matters not fully deliberated herein, it is proposed to the shareholders meeting that the Board of Directors be authorized to handle the matters in accordance with the laws and regulations.

Resolutions:

討論案三

董事會提

案由：本公司辦理私募普通股案，提請討論。

說明：一、本公司為引進策略性投資人及增強與策略合作伙伴的長期合作關係，以利公司長期經營與業務發展，擬依證券交易法第四十三條之六等規定，以私募方式辦理現金增資發行普通股新股(以下簡稱「本次私募普通股」)，預計私募普通股總數不超過2,000,000股（每股面額新台幣10元），預計增加實收資本額總額不超過新台幣20,000,000元。

10

---

二、依證券交易法第四十三條之六及「公開發行公司辦理私募有價證券應注意事項」規定，說明如下：

(一) 私募價格訂定之依據及合理性：

1. 本次私募普通股每股價格之訂定，以不低於本公司定價日前下列二基準計算價格較高者之八成五訂定之：
   (1) 定價日前一、三或五個營業日擇一計算普通股收盤價簡單算數平均數扣除無償配股除權及配息，並加回減資反除權後之股價；或
   (2) 定價日前三十個營業日普通股收盤價簡單算數平均數扣除無償配股除權及配息，並加回減資反除權後之股價。

2. 實際定價日及實際私募價格於不低於股東會決議成數之範圍內授權董事會依前述訂價依據，視日後洽定特定人情形及市場狀況決定之。

3. 本次私募價格之訂價方式係依據「公開發行公司辦理私募有價證券應注意事項」規定，並考量公司未來展望以及私募有價證券之轉讓時點、對象及數量均有嚴格限制，且三年內不得洽辦上市掛牌，流動性較差等因素，故本次私募價格之訂定應屬合理，對股東權益不致有重大影響。

(二)特定人選擇方式：

1. 本次私募普通股之對象以符合證券交易法第43條之6及金融監督管理委員會112年9月12日金管證發字第1120383220號函之規定擇定特定人，並以策略性投資人為限。

2. 應募人擬為策略性投資人：

(1) 應募人之選擇方式與目的：因本公司長期經營與業務發展需要，將選擇對本公司之未來營運能產生直接或間接助益者為優先考量，並能有助於本公司擴大業務市場，強化客戶關係，或提升業務開發整合效益，或能提高技術，並能認同本公司經營理念之策略性投資人。

(2) 必要性：本次選定應募人之目的係為引進策略性投資人及增強與策略合作伙伴的長期合作關係，透過策略性投資人可提升本公司之長期競爭力及營運效益，故有其必要性。

(3) 預計效益：藉由策略性投資人之經驗、技術、知識、品牌聲譽及市場通路等優勢，經由策略合作、共同開發業務或市場整合等方式，預計將有助於本公司降低營運成本、擴大業務版圖，以提高本公司未來營運績效。

1. 目前尚無已洽定之應募人。

(三) 辦理私募之必要理由：

1. 不採用公開募集之理由：考量資本市場狀況、發行成本、私募方式之籌資時效性及可行性，以及私募股票有三年內不得自由轉讓之限制等因素，

11

---

較可確保並強化與策略合作伙伴間更緊密的長期合作關係，故本次不採用公開募集而擬以私募方式辦理現金增資發行新股。

1. 私募之額度：本次私募普通股總額度在不超過 2,000,000 股額度內，將於股東會決議之日起一年內一次或分次(最多不超過三次)辦理。

2. 本次私募普通股各分次辦理之資金用途及預計達成效益如下：

辦理次數	資金用途	預計達成效益
分一次辦理	尋求與國內外科技大廠及產業基金進行技術合作、市場業務合作或策略聯盟機會，同時充實營運週轉金及因應公司長期營運發展所需	降低公司之經營風險，強化財務結構，提升本公司未來營運績效之效益
分二次辦理
分三次辦理

(四) 董事會決議辦理本次私募普通股前一年內經營權並無發生重大變動，且本次私募普通股之應募人將以策略性投資人為限，將對本公司業務發展有正面助益。本公司未來選定本次私募普通股之應募人時，將以該次私募普通股交付日起一年內經營權不發生重大變動為原則。

(五) 其他應敘明事項：

1. 本次私募之普通股，權利義務原則上與本公司已發行之普通股相同，惟依證券交易法第 43 條之 8 規定，除依該條文規定之轉讓對象及條件外，原則上私募之普通股於交付日起三年內不得自由轉讓，本公司於交付日起滿三年後，擬依證券交易法等相關規定，先取具台灣證券交易所核發符合上市標準之同意函，再向主管機關申報補辦本次私募普通股公開發行及申請上市交易。

2. 本次私募普通股計畫之主要內容，包括實際私募股數、實際私募價格、應募人之選擇、基準日、發行條件、計畫項目、資金用途及進度、預計產生效益及其他相關事宜等，暨其他一切有關發行計畫之事項，擬提請股東會授權董事會視市場狀況調整、訂定及辦理，未來如因法令變更或主管機關要求修正或基於營運評估、或因客觀環境需要變更時，亦授權董事會全權處理之。

3. 除上述授權範圍外，擬提請股東會授權董事長，代表本公司簽署與商議一切有關私募普通股之契約及文件，並為本公司辦理一切有關發行私募普通股所需之事宜。

決議：

---

Discussion No.3 :

Proposed by the Board of Directors

The Company’s Issuance of Common Shares through Private Placement. Please proceed to discuss.

Explanation:

1. In order to introduce strategic investors and strengthen the Company’s long-term cooperative relationship with strategic partners, so as to facilitate the Company’s long-term operation and business development, it is proposed to raise capital in cash by issuance of new common shares through private placement (hereinafter referred to as the “Privately Placed Common Shares”), in compliance with the provisions of Article 43-6 of the Securities and Exchange Act and relevant regulations. It is expected that the aggregate number of Privately Placed Common Shares will not exceed 2,000,000 shares (at par value of NT$10 per share) and the increased paid-in capital amount will not exceed NT$ 20,000,000.

2. According to the provisions of Article 43-6 of the Securities and Exchange Act and the “Directions for Public Companies Conducting Private Placements of Securities”, the further explanations are set forth as follows:

(1) The basis and rationality of the pricing of private placement

A. As to the pricing of the Privately Placed Common Shares, the price per share shall not be lower than 85% of the higher price of the following two calculations before the pricing date:

i. The simple average closing price of the Company’s common shares is calculated based on either the 1, 3, or 5 business days before the pricing date and is adjusted upon distribution of stock dividends and cash dividends, and capital reduction; or

ii. The simple average closing price of the Company’s common shares is calculated based on 30 business days before the pricing date and is adjusted upon distribution of stock dividends and cash dividends, and capital reduction.

B. The actual pricing date and the actual price of common shares to be issued through private placement shall not be less than the range approved by the resolution of the Company shareholders’ meeting. The board of directors of the Company will be authorized to determine the price based on the aforesaid price, future specific persons’ situation and market conditions.

C. The pricing method of this private placement price is based on the "Directions for Public Companies Conducting Private Placements of Securities", considering that the Company’s prospects, the timing, object, and quantity of transfer of private placement of securities are strictly limited. Moreover, it is also not possible to be listed on the TWSE within three years and the liquidity is poor. Therefore, the pricing of the private placement of this fiscal year shall be reasonable and would cause no major impact on shareholders’ equity.

(2) Methods for selecting specific persons

A. The proposed investor to subscribe for the Privately Placed Common Shares shall meet the qualification under Article 43-6 of the Securities Exchange Act and the Decree No.

13

---

1120383220 of the Financial Supervisory Commission issued on September 12, 2023, and shall be a strategic investor.

B. The proposed investors are intended to be strategic investors:

i. Method and purpose of selecting investors: Due to the Company's long-term business and business development needs, it will give priority to those who may directly or indirectly contribute to the future operation of the Company, and can help the Company expand its business, strengthen customer relations, or enhance business development integration benefits, or can improve technology, and can recognize the Company's business strategy.

ii. Necessity: The purpose of selecting offerees is to introduce strategic investors and strengthen long-term cooperation with strategic partners. Through strategic investors, the long-term competitiveness and operational effectiveness of the Company can be enhanced, which is necessary.

iii. Expected Benefits: It is expected that through strategic investors' experience, technology, knowledge, brand reputation, and market access, the Company can cooperate with such investors in strategic cooperation, joint business development or market integration, which will help the Company to reduce operating costs and expand its sales market to improve the Company's future operating performance.

C. There are no offerees at present.

(3) Necessary reasons for the private placement:

A. Reasons for not adopting public offerings: Considering factors such as capital market conditions, offering costs, timeliness and feasibility of fundraising for private placements, and restrictions on private placement of shares that cannot be freely transferred within three years, etc. In this way, it can ensure and strengthen strategic partnerships in a closer long-term cooperation relationship. Therefore, public offering is not adopted at this time, and a private placement to increase capital in cash by issuance of new share is conducted instead.

B. The size of the proposed private placement: The aggregate number of this Privately Placed Common Shares shall not exceed 2,000,000 shares and will be issued once or in installments (up to a maximum of three times) within one year from the date of the resolution of the shareholders' meeting.

C. The use of proceeds raised from issuance of Privately Placed Common Shares and the estimated benefits processed in different tranches.

Processing times	Use of proceeds	Expected results
Once in a single transaction	Seek opportunities for technical cooperation, business cooperation or strategic alliances with domestic and foreign big tech companies or	Reduce the Company's operating risks, strengthen its financial structure, and improve the Company's
Twice in two transactions

---

Three times in three transactions	industrial funds, and at the same time, enrich working capital and meet the Company's long-term operational development needs	future operating performance

(4) There is no occurrence of significant change of control event within the past year preceding the day when the Company's board of directors resolves this private placement plan. As the investors subscribe to the Privately Placed Common Shares will be limited to strategic investors, the proposed private placement may have a positive contribution to the Company's business development. The selection of strategic investors by way of this private placement will be subject to the principle that no significant change of control event would occur within one year following the delivery of Privately Placed Common Shares.

(5) Other matters that should be stated:

A. The rights and obligations contain in the Privately Placed Common Shares are in principle the same as the common shares issued by the Company; however, according to the provisions of Article 43-8 of the Securities and Exchange Act, in addition to the objects and conditions of the assignment as prescribed by the provisions, in principle, the Privately Placed Common Shares shall not be freely transferred within three years from the date of delivery. After the full three years from the delivery date, the company plans to obtain a consent letter from the Taiwan Stock Exchange in accordance with the relevant provisions of the Securities and Exchange Act, etc. The Company shall apply for re-issuance of the public offering of the Privately Placed Common Shares and application for the listing of the Privately Placed Common Shares with the competent authority.

B. The terms and conditions of the proposed issuance of Privately Placed Common Shares, including the actual number of Privately Placed Common Shares, the final private placement price, selection of investors, record date, issuance conditions, project items, use of proceeds and progress, expected benefits, and all other matters related to the issuance plan, will be brought to the shareholders' meeting and request authorization for the board of directors to adjust, determine and handle based on the market conditions, and if future changes such as due to amendments in laws or regulations or when required by the competent authority or based on operational assessment, or due to changes in the objective environment, the board of directors of the Company will be authorized to handle it completely.

C. In addition to the aforesaid scope of authorization, it is proposed that the Chairman is authorized to sign and negotiate all contracts and documents relating to Privately Placed Common Shares on behalf of the Company, and to handle all necessary matters regarding to Privately Placed Common Shares for the Company.

Resolutions:

---

討論案四

董事會 提

案由：解除董事競業禁止案，提請討論。

說明：一、依本公司章程第30.4條規定「董事如在公司業務範圍內為自己或他人從事行為，應在從事該行為之前，於股東會上向股東揭露該等利益的主要內容，並在股東會上依特別（重度）決議取得許可」。

二、本公司董事有為其自己或他人從事公司營業範圍內事務的行為，在無損及本公司利益之前提下，擬請股東會同意解除董事之競業禁止限制。

三、擬解除董事候選人競業禁止限制之內容如下：

職稱	姓名	目前兼任他公司之名稱及職務
董事	張國威	安茂微電子股份有限公司董事

決議：

Discussion No.4 :

Proposed by the Board of Directors

Release the Prohibition on Directors from Participating in Competitive Business. Please proceed to discuss.

Explanation:

1. In accordance with the Article 30.4 of the Memorandum and Articles of Association of the Company, a Director who engages in conduct either for himself or on behalf of another person within the scope of the Company's business, shall disclose to Members, at a general meeting prior to such conduct, a summary of the major elements of such interest and obtain the ratification of the Members at such general meeting by a Supermajority Resolution vote.

2. Since the Directors of the Company may engage in conduct within the scope of the Company's business, it is proposed to Annual General Meeting release the prohibition on newly Directors who hold concurrent position in other companies from participation in competitive business without prejudice to the Company's interests.

3. Please refer to the table below for the Director candidates' positions holding in other companies.

Position	Name	Position holding in other companies
Director	Guo-Wei Chang	Director of AME, Inc.

Resolutions:

四、臨時動議 Ad Hoc Motion